<DOC>
	<DOCNO>NCT01251809</DOCNO>
	<brief_summary>This assessment efficacy safety three different dos pegylated recombinant asparaginase ( PEG-rASNase ) comparison Oncaspar® treatment adult de novo acute lymphoblastic leukaemia ( ALL ) . This study provide first data determine specific asparaginase dose yield various duration L-asparagine ( ASN ) depletion require within different treatment phase ALL therapy .</brief_summary>
	<brief_title>Trial Oncaspar® Three Doses Pegylated Recombinant Asparaginase Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Pegaspargase</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Previously untreated acute lymphoblastic leukaemia ( proB , common , preB , early T , thymic T , mature T ) Age 18 year 55 year Treatment accord German Multicenter Trials adult Acute Lymphoblastic Leukaemia ( GMALL ) 07/2003 protocol subsequent GMALL protocols patient de novo ALL Written inform consent Women childbearing potential partner men childbearing potential must use highly effective method contraception Negative pregnancy test woman childbearing potential Patients Philadelphia chromosome ( BCRABL ) positive ALL Severe comorbidity leukaemiaassociated complication Known hypersensitivity asparaginase History severe pancreatitis History thrombosis pulmonary embolism Preexisting clinically relevant coagulopathy Liver dysfunction ( e.g . acute current hepatitis , alcohol drug abuse ) history clinically relevant liver disease Bilirubin &gt; 1.5 x Upper Limit Norm ( ULN ) Other current malignancy Severe psychiatric illness circumstance may compromise cooperation patient ability give inform consent Body mass index &gt; 30 kg/m² Known pregnancy , breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Asparaginase</keyword>
	<keyword>ALL</keyword>
</DOC>